class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
SHELLFISH ALLERGY: same caution as glucosamine sulfate. Warfarin interaction applies. Blood glucose monitoring in diabetes. Less evidence than sulfate form for OA.
Hydrochloride salt form of glucosamine. Less studied than sulfate form — GAIT trial (NIH) used HCl form and showed less benefit than European sulfate studies. Same shellfish-derived source concerns.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly safe | — |
| Pregnancy | Possibly safe | — |
| Elderly | Possibly safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)